Assignee
DECIBEL THERAPEUTICS INC
US·12 granted patents·24 pending applications·34 citations·filing 2019–2025
Top patents by PatentIndex Score
36 records- 0196US11071751B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·5 cites·20 claims
- 0293US11857567B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·22 claims
- 0393US10709732B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·33 claims
- 0489US11690870B2Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 4, 2023·2 cites·10 claims
- 0588US12252520B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·2 cites·13 claims
- 0688US11660353B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2019·Granted May 30, 2023·9 cites·11 claims
- 0785US10813947B1Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·5 cites·7 claims
- 0883US2024350533A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0982US12233136B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2019·Granted Feb 25, 2025·3 cites·25 claims
- 1078US2025381219A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1175US2025127926A1Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1274US2024226141A9Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1372US2026035716A1Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1470US2024226326A9Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1567US2024352483A1Modified rep-cap plasmids and uses thereofDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1666US2024309399A1Methods and compositions for administering otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1765US12410442B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 1861US12545930B2Cochlear inner hair cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Granted Feb 10, 2026·0 cites·12 claims
- 1960US2025304637A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2059US2025127928A1Gjb2 regulatory elements and uses thereofDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2158US12589168B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Granted Mar 31, 2026·0 cites·4 claims
- 2258US2024401079A1Stereocilin promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2357US2025319205A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2457US2026034248A1Slc26a4 regulatory elements and uses thereofDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2555US2024285803A1Compositions and methods for cell type-specific gene expression in the inner earDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2654US2022288236A1Cochlear outer hair cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2754US2022054640A1Compositions and methods for the delivery of therapeutic agents across the round window membraneDECIBEL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2854US2024218391A1Vestibular supporting cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2954US2024002839A1Crispr sam biosensor cell lines and methods of use thereofDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3054US2022331449A1Vestibular supporting cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3152US2024216540A1Compositions and methods for treating sensorineural hearing loss using stereocilin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3252US2024226331A9Methods and compositions for reducing nucleic acid vector-induced toxicity in the inner earDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3352US2023061456A1Methods and compositions for generating type 1 vestibular hair cellsDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3451US2024148905A1Methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3548US2023181767A1Compositions and methods for promoting hair cell regenerationDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3647US12534739B2AAV1 vectors and uses thereof for treatment of otic indicationsDECIBEL THERAPEUTICS INC·Filed 2019·Granted Jan 27, 2026·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when DECIBEL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →